Aberdeen Group
SPRY icon

Aberdeen Group’s ARS Pharmaceuticals SPRY Stock Holding History

Aberdeen Group’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$26.2M Buy
1,502,575
+499,916
+50% +$8.72M 0.04% 335
2025
Q1 		$12.6M Buy
+1,002,659
New +$12.6M 0.02% 511